Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | AKT3 |
| Upstream (Parents) |
|---|
| (<<) ALDOA → AKT3 |
| (<<) BMP2 → AKT3 |
| (<<) CABC1 → AKT3 |
| (<<) CAMKK1 → AKT3 |
| (<<) CBL → AKT3 |
| (<<) CDK6 → AKT3 |
| (<<) CHODL → AKT3 |
| (<<) COTL1 → AKT3 |
| (<<) EPN3 → AKT3 |
| (<<) FZD7 → AKT3 |
| (<<) GYS1 → AKT3 |
| (<<) IQSEC2 → AKT3 |
| (<<) KCNJ2 → AKT3 |
| (<<) KCTD12 → AKT3 |
| (<<) LRRC8C → AKT3 |
| (<<) MAP1B → AKT3 |
| (<<) MPHOSPH6 → AKT3 |
| (<<) NOC3L → AKT3 |
| (<<) PAK4 → AKT3 |
| (<<) PIK3R2 → AKT3 |
| (<<) ROBO3 → AKT3 |
| (<<) SOX8 → AKT3 |
| (<<) SPDEF → AKT3 |
| (<<) THRA → AKT3 |
| (<<) TMEM158 → AKT3 |
| (<<) TNFAIP3 → AKT3 |
| (<<) TPM1 → AKT3 |
| Downstream (Children) |
|---|
| AKT3 → ETS1 (>>) |
| AKT3 → GAL (>>) |
| AKT3 → JAG1 (>>) |
